Clinical validation study confirms PromarkerD

Proteomics International announced today results from its validation clinical study showing that the PromarkerD blood test can predict the onset of diabetic kidney disease better than any current measure. These findings will be presented by Professor Tim Davis, from The University of Western Australia Medical School, at the American Diabetes Association’s 77th Annual Scientific Sessions (ADA), 9-13th June, in San Diego, California.

Media Release

Click here to find out more about PromarkerD test.


  • This field is for validation purposes and should be left unchanged.